MyD-88 L265P mutations are present in some cases of vitreoretinal lymphoma

Jose S. Pulido; Diva R. Salomao; Lori A. Frederick; David S. Viswanatha

doi:10.1097/IAE.0000000000000589

MyD-88 L265P mutations are present in some cases of vitreoretinal lymphoma

Jose S. Pulido, Diva R. Salomao, Lori A. Frederick, David S. Viswanatha

Ophthalmology

Research output: Contribution to journal › Article › peer-review

17 Scopus citations

Abstract

Purpose: To determine whether Myd88 L265P mutations occur in diffuse large B-cell vitreoretinal lymphomas. Methods: The formalin-fixed paraffin-embedded cells from three patients with classic clinical findings of vitreoretinal lymphoma that also had histologic confirmation were evaluated using a validated amplification-refractory mutation system polymerase chain reaction to determine the presence of the mutation. Results: The 74 ± 2 base pair product seen from the mutated Myd-88 protein was noted in 2 of the 3 cases. Conclusion: Myd-88 L265P constitutive activating mutations are present in at least some cases of the diffuse large B-cell lymphoma form of vitreoretinal lymphoma. Further studies on the incidence of this mutation in retinal lymphomas are warranted.

Original language	English (US)
Pages (from-to)	624-627
Number of pages	4
Journal	Retina
Volume	35
Issue number	4
DOIs	https://doi.org/10.1097/IAE.0000000000000589
State	Published - Apr 1 2015

Keywords

CNS lymphoma
Myd-88
Myd-88 L265P mutation
diffuse large B-cell lymphoma
vitreoretinal lymphoma

ASJC Scopus subject areas

Ophthalmology

Access to Document

10.1097/IAE.0000000000000589

Cite this

@article{424bafe65dc849e98b9fd8f215fa766e,

title = "MyD-88 L265P mutations are present in some cases of vitreoretinal lymphoma",

abstract = "Purpose: To determine whether Myd88 L265P mutations occur in diffuse large B-cell vitreoretinal lymphomas. Methods: The formalin-fixed paraffin-embedded cells from three patients with classic clinical findings of vitreoretinal lymphoma that also had histologic confirmation were evaluated using a validated amplification-refractory mutation system polymerase chain reaction to determine the presence of the mutation. Results: The 74 ± 2 base pair product seen from the mutated Myd-88 protein was noted in 2 of the 3 cases. Conclusion: Myd-88 L265P constitutive activating mutations are present in at least some cases of the diffuse large B-cell lymphoma form of vitreoretinal lymphoma. Further studies on the incidence of this mutation in retinal lymphomas are warranted.",

keywords = "CNS lymphoma, Myd-88, Myd-88 L265P mutation, diffuse large B-cell lymphoma, vitreoretinal lymphoma",

author = "Pulido, {Jose S.} and Salomao, {Diva R.} and Frederick, {Lori A.} and Viswanatha, {David S.}",

year = "2015",

month = apr,

day = "1",

doi = "10.1097/IAE.0000000000000589",

language = "English (US)",

volume = "35",

pages = "624--627",

journal = "Retina",

issn = "0275-004X",

publisher = "Lippincott Williams and Wilkins",

number = "4",

}

TY - JOUR

T1 - MyD-88 L265P mutations are present in some cases of vitreoretinal lymphoma

AU - Pulido, Jose S.

AU - Salomao, Diva R.

AU - Frederick, Lori A.

AU - Viswanatha, David S.

PY - 2015/4/1

Y1 - 2015/4/1

N2 - Purpose: To determine whether Myd88 L265P mutations occur in diffuse large B-cell vitreoretinal lymphomas. Methods: The formalin-fixed paraffin-embedded cells from three patients with classic clinical findings of vitreoretinal lymphoma that also had histologic confirmation were evaluated using a validated amplification-refractory mutation system polymerase chain reaction to determine the presence of the mutation. Results: The 74 ± 2 base pair product seen from the mutated Myd-88 protein was noted in 2 of the 3 cases. Conclusion: Myd-88 L265P constitutive activating mutations are present in at least some cases of the diffuse large B-cell lymphoma form of vitreoretinal lymphoma. Further studies on the incidence of this mutation in retinal lymphomas are warranted.

AB - Purpose: To determine whether Myd88 L265P mutations occur in diffuse large B-cell vitreoretinal lymphomas. Methods: The formalin-fixed paraffin-embedded cells from three patients with classic clinical findings of vitreoretinal lymphoma that also had histologic confirmation were evaluated using a validated amplification-refractory mutation system polymerase chain reaction to determine the presence of the mutation. Results: The 74 ± 2 base pair product seen from the mutated Myd-88 protein was noted in 2 of the 3 cases. Conclusion: Myd-88 L265P constitutive activating mutations are present in at least some cases of the diffuse large B-cell lymphoma form of vitreoretinal lymphoma. Further studies on the incidence of this mutation in retinal lymphomas are warranted.

KW - CNS lymphoma

KW - Myd-88

KW - Myd-88 L265P mutation

KW - diffuse large B-cell lymphoma

KW - vitreoretinal lymphoma

UR - http://www.scopus.com/inward/record.url?scp=84964240082&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84964240082&partnerID=8YFLogxK

U2 - 10.1097/IAE.0000000000000589

DO - 10.1097/IAE.0000000000000589

M3 - Article

C2 - 25768255

AN - SCOPUS:84964240082

SN - 0275-004X

VL - 35

SP - 624

EP - 627

JO - Retina

JF - Retina

IS - 4

ER -

MyD-88 L265P mutations are present in some cases of vitreoretinal lymphoma

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this